Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sanna Aalto"'
Publikováno v:
Haematologica, Vol 92, Iss 6 (2007)
Background and Objectives An HLA-mismatched donor and a T-cell-depleted graft are known risk factors for Epstein-Barr virus (EBV) reactivation after stem cell transplantation. We studied the frequency and outcome of serum EBV DNA levels in patients t
Externí odkaz:
https://doaj.org/article/987c5846618c427fb3de4c3b5e97adbc
Autor:
Klaus Hedman, Sanna Aalto, T. Martelius, Anne Nihtinen, Veli-Jukka Anttila, Maija Lappalainen
Publikováno v:
Clinical Microbiology and Infection. 16(6):657-662
Epstein--Barr virus (EBV) is important in the development of post-transplant lymphoproliferative disease in allogeneic stem cell and solid organ transplant recipients. We have studied the clinical significance of EBV DNAaemia among nontransplant pati
Autor:
Sakari Knuutila, Klaus Hedman, Liisa Volin, Tapani Ruutu, Heli Piiparinen, Sanna Aalto, Petri S. Mattila, Jussi Tarkkanen, Eeva Juvonen
Publikováno v:
Journal of Clinical Virology. 28:275-283
Background: Lymphoproliferative disease (PTLD) is a life-threatening complication of organ transplantation. In matched, allogeneic, non-T-cell-depleted stem-cell transplantations (SCT) the disease develops early but has been thought to be rare. Objec
Autor:
Petri S. Mattila, Severi Mattila, Eeva Auvinen, Sanna Aalto, Klaus Hedman, Jussi Tarkkanen, Heikkilä L, Markku S. Nieminen
Publikováno v:
Clinical Transplantation. 15:337-342
The presence of Epstein-Barr virus (EBV), human papilloma virus (HPV), and cytomegalovirus (CMV) was studied in 20 patients who developed malignancies after heart transplantation in the Helsinki University Central Hospital. The tumors were analyzed f
Autor:
Heikki Haario, Liisa Volin, Jussi Tarkkanen, Klaus Hedman, Eeva Juvonen, Tapani Ruutu, Sanna Aalto
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 45(10)
Background We wanted to determine the clinical significance and predictability of Epstein-Barr virus (EBV) infections among a large cohort of recipients of allogeneic, unselected stem cell transplants. Methods During 1988-1999, a total of 5479 consec
Autor:
Klaus Hedman, Johanna Arola, Krister Höckerstedt, Irmeli Lautenschlager, Leena Halme, Heli Piiparinen, Sanna Aalto, Raisa Loginov
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 37(2)
Background Post-transplant lymphoproliferative disease (PTLD) causes significant morbidity and mortality in transplantation. The clinical significance of Epstein-Barr virus (EBV) in the development of PTLD is clear, but not all EBV-reactivations caus
Autor:
Klaus Hedman, Tapani Ruutu, Jussi Tarkkanen, Sanna Aalto, Petri S. Mattila, Liisa Volin, Eeva Juvonen, Sakari Knuutila
Publikováno v:
Bone marrow transplantation. 32(1)
The occurrence of post-transplant lymphoproliferative disorder (PTLD) in relation to immunosuppressive treatment was determined in 257 patients treated with non-T-cell-depleted allogeneic stem cell transplantation from an HLA-matched sibling (173 pat
Autor:
Benedikt Weissbrich, Elina Vuori, Klaus Hedman, Kimmo Linnavuori, Heikki Peltola, Joerg Schubert, Lea Hedman, Sanna Aalto
Publikováno v:
Journal of medical virology. 56(3)
Serological diagnosis of herpes virus infections is hampered by concurrent expression of IgM for heterologous members of this virus family. To assess the frequency of such multiple diagnostic findings and to understand their etiology, we sought by us
Publikováno v:
Blood. 106:3233-3233
The course of serum EBV-PCR positivity and its impact on the outcome of allogeneic stem cell transplantation (Tx) has not been known well until recently. We have studied retrospectively with quantitative real-time EBV-PCR (qPCR) 5445 serum samples (m
Publikováno v:
Blood. 104:2242-2242
We have studied prospectively the incidence of EBV DNAemia and its early treatment in 131 adult allogeneic high risk SCT recipients transplanted during the years 2000 to 2003. Based on our retrospective experience, high risk patients for EBV infectio